Search research articles
Contact Us
Filters
Showing results (41-50 of 54) with videos related to
Page
of 6
Sort By:
Cancer
|
May 7, 2008
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
Javier G Blanco, Wendy M Leisenring, Vanessa M Gonzalez-Covarrubias, et al.
Pharmacogenetics and Genomics
|
June 7, 2021
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia
Jesús Alonso Gándara-Mireles, Ismael Lares-Asseff, Elio Aarón Reyes Espinoza, et al.
Pharmacogenetics
|
November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies
Javier G Blanco, Mathew J Edick, Michael L Hancock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation
Ashley C Woods, E Dianne Pulte, Xin Wang, et al.
Frontiers in Pharmacology
|
February 22, 2021
Genotype Analysis of <i>ABCC1</i>, <i>NCF4</i> and <i>CBR3</i> Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
Jesús Alonso Gándara-Mireles, Ismael Lares-Asseff, Elio Aarón Reyes Espinoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2011
Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group
Javier G Blanco, Can-Lan Sun, Wendy Landier, et al.
Cancer
|
May 16, 2020
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
JACC. Cardiooncology
|
January 11, 2024
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS
Noha Sharafeldin, Liting Zhou, Purnima Singh, et al.
JACC. Cardiooncology
|
July 3, 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
Purnima Singh, David K Crossman, Liting Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
Nina Kim, E Dianne Pulte, Lori A Ehrlich, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 54) with videos related to
Sort By:
Page
of 6
Cancer
|
May 7, 2008
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
Javier G Blanco, Wendy M Leisenring, Vanessa M Gonzalez-Covarrubias, et al.
Pharmacogenetics and Genomics
|
June 7, 2021
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia
Jesús Alonso Gándara-Mireles, Ismael Lares-Asseff, Elio Aarón Reyes Espinoza, et al.
Pharmacogenetics
|
November 20, 2002
Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies
Javier G Blanco, Mathew J Edick, Michael L Hancock, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2025
FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation
Ashley C Woods, E Dianne Pulte, Xin Wang, et al.
Frontiers in Pharmacology
|
February 22, 2021
Genotype Analysis of <i>ABCC1</i>, <i>NCF4</i> and <i>CBR3</i> Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population
Jesús Alonso Gándara-Mireles, Ismael Lares-Asseff, Elio Aarón Reyes Espinoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 2011
Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group
Javier G Blanco, Can-Lan Sun, Wendy Landier, et al.
Cancer
|
May 16, 2020
Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report
Purnima Singh, Xuexia Wang, Lindsey Hageman, et al.
JACC. Cardiooncology
|
January 11, 2024
Gene-Level Analysis of Anthracycline-Induced Cardiomyopathy in Cancer Survivors: A Report From COG-ALTE03N1, BMTSS, and CCSS
Noha Sharafeldin, Liting Zhou, Purnima Singh, et al.
JACC. Cardiooncology
|
July 3, 2023
Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report
Purnima Singh, David K Crossman, Liting Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 24, 2025
US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
Nina Kim, E Dianne Pulte, Lori A Ehrlich, et al.
Page
of 6